Susan Quaggin

Last updated
Susan Quaggin
NationalityCanadian
Alma mater University of Toronto Faculty of Medicine
Northwestern University Feinberg School of Medicine
AwardsCarl W. Gottschalk Research Scholar Award
Joe Doupe Young Investigator Award
Scientific career
Fields Nephrology, hypertension

Susan E. Quaggin is a Canadian nephrologist. She is the Charles Horace Mayo Professor of Medicine at Northwestern University Feinberg School of Medicine, Director of the Feinberg Cardiovascular Research Institute and chief of the Division of Nephrology.

Contents

Early life and education

Quaggin attended Branksome Hall, where she met her future husband Kevin Smith who attended Royal St. George's College. [1] She attended the University of Toronto Faculty of Medicine, where she received the Carl W. Gottschalk Research Scholar Award from the American Society of Nephrology, and completed her post-doctoral fellowship at the Yale School of Medicine. In 1997, Quaggin returned to Toronto to study developmental biology with Janet Rossant at the Lunenfeld Institute of Mount Sinai Hospital. [2] It was during her lab research with Rossant that she discovered a gene critical for the development of the kidneys, heart and lungs. [3] By 2000, Quaggin and her research team were cloning mice lacking that vital gene in order to study their kidneys. [2] The next year, she received the Joe Doupe Young Investigator Award. [4]

Career

Quaggin accepted a faculty position at the University of Toronto, where she spent 13 years as a senior scientist at the Samuel Lunenfeld Research Institute, a nephrologist at St. Michael's Hospital, and the Gabor-Zellerman Professor in renal medicine. [5] In 2006, she was named a Tier 2 Canada Research Chair in Vascular Biology, which granted her $500,000 over 5 years. [6] Two years later, Quaggin and Laura Barison discovered that VEGF inhibitors, an antibody used to treat many forms of cancer, was causing renal failure. [7] She was also elected chair for the Abstract Selection Committees for Glomerular Disease with the American Society of Nephrology. [8] The next year, Quaggin was the recipient of the 2009 KFOC Medal for Research Excellence by the Kidney Foundation of Canada. [9]

In 2011, Quaggin was appointed the Gabor-Zellerman Chair in Renal Research in the Department of Medicine at the University of Toronto [10] and Deputy Editor and for Journal of the American Society of Nephrology. [8] Quaggin also co-published a study in the journal Cell regarding the effects of VEGF in the kidney, including how it will impact drug therapies and treatment. [11] In 2012, Quaggin was encouraged to join the faculty at Northwestern University by Eric G. Neilson. [5] She was eventually appointed the Charles Horace Mayo Professor of Medicine at Northwestern University Feinberg School of Medicine, and as Director of the Feinberg Cardiovascular Research Institute and chief of the Division of Nephrology. [12]

At the Northwestern University Feinberg School of Medicine, Quaggin and Amani Fawzi discovered a cause of glaucoma in animals and began developing an eye drop aimed at curing the disease. Together with her PhD student Ben Thomson, Quaggin developed one of the first models of animals with the glaucoma disease. [13] In May 2013, she was elected to the Association of American Physicians. [14] She also received the Alfred Newton Richards Award for basic science research in the field by the International Society of Nephrology. [3] Eventually, Q BioMed Inc. gained the rights to acquire Mannin Research Inc., which was developing the eyedrops. [15]

In 2015, she was appointed the American Society of Nephrology's Councilor until 2022, [16] sat on their Public Policy Board, and their and Blood and Lymphatic Development of the Kidney Board. [8] In 2019, she was elected to the National Academy of Medicine. [17]

In 2023, she became the first woman Chair of the Department of Medicine at the Northwestern University Feinberg School of Medicine [18] .

Related Research Articles

<span class="mw-page-title-main">Nephrology</span> Medical study concerned with the kidneys

Nephrology is a specialty of adult internal medicine and pediatric medicine that concerns the study of the kidneys, specifically normal kidney function and kidney disease, the preservation of kidney health, and the treatment of kidney disease, from diet and medication to renal replacement therapy. The word "renal" is an adjective meaning "relating to the kidneys", and its roots are French or late Latin. Whereas according to some opinions, "renal" and "nephro" should be replaced with "kidney" in scientific writings such as "kidney medicine" or "kidney replacement therapy", other experts have advocated preserving the use of renal and nephro as appropriate including in "nephrology" and "renal replacement therapy", respectively.

<span class="mw-page-title-main">Robert Provenzano</span> American physician

Robert Provenzano is an American nephrologist. He is also an Associate Clinical Professor of Medicine at Wayne State University School of Medicine.

<span class="mw-page-title-main">American Society of Nephrology</span> U.S. professional organization

Founded in 1966, the American Society of Nephrology (ASN) is the world's largest professional society devoted to the study of kidney disease. Composed of over 20,000 physicians and scientists, ASN promotes expert patient care, advances medical research, and educates the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients.

<span class="mw-page-title-main">Carmine Zoccali</span>

Carmine Zoccali is an Italian nephrologist and a clinical investigator. He has contributed to research in several fields, most notably hypertension and cardiovascular complications in chronic kidney disease (CKD), CKD progression and clinical epidemiology of kidney diseases at large. He is known for his studies on cardiovascular risk in CKD and dialysis patients. He was among the earliest investigators that focused on the relevance of endothelial dysfunction and inflammation for the high risk of cardiovascular disease in these populations. In this research area, he was the first to link endogenous inhibitors of the nitric oxide system with death and cardiovascular disease. and the first to document a relationship between sympathetic over-activity and these outcomes Dr Zoccali is a practicing specialist in Nephrology, with a national qualification for the full professorship in Nephrology. He is also a specialist in hypertension, certified by the European Society of Hypertension (ESH).

Vlado Perkovic is an Australian renal physician and researcher who is the Provost at the University of New South Wales, Sydney, having previously been Dean of Medicine & Health at that University between 2019 and 2023.

<span class="mw-page-title-main">Stewart Cameron (nephrologist)</span> British nephrologist (1934–2023)

John Stewart Cameron was a British nephrologist.

<span class="mw-page-title-main">Jochen Reiser</span> German nephrologist (born 1971)

Jochen Reiser is a physician-scientist and a healthcare leader. He is the President of the University of Texas Medical Branch (UTMB) and CEO of the UTMB Health System, which includes the oldest Medical School and Nursing School in the state of Texas. As Chief Executive Officer, he oversees the enterprise which includes multiple campuses, five health science colleges, the Galveston National Laboratory (BSL-4) and the Correctional Health Care Services for most of Texas. Before UTMB, he served as the Ralph C Brown MD Professor and the Chairman of Medicine at Rush University Medical Center. Dr. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Dr. Reiser discovered the role of suPAR as a global, circulating risk factor for chronic kidney disease (CKD) as well as for acute kidney injury (AKI). suPAR is investigated as potential causative agent contributing to many kidney diseases including focal segmental glomerulosclerosis (FSGS). These studies have broad clinical significance and lay the foundation for creation of novel diagnostics and pharmaco-therapeutics with potential benefit for a large patient population. His studies on suPAR molecule were featured in Science in 2018. Dr. Reiser has been an advocate of science and innovation for two decades and was named as an inventor on multiple patents. He is co-founder of Cambridge, MA-based Walden Biosciences, an ARCH Venture Partners joint-venture biopharmaceutical portfolio company dedicated to develop first-in-class therapeutics for kidney diseases.

Professor David Wayne Johnson is an Australian nephrologist known for kidney treatments and transplants in Australia. In 2009 he was a Queensland State Finalist for Australian of the Year, for his work in the early recognition and care of people with chronic kidney disease and specifically for his work in detection of chronic kidney disease.

Donald Wayne Seldin was an American nephrologist. He worked at University of Texas Southwestern Medical Center and served as chair of the department of medicine for 36 years.

The Polish Society of Nephrology is a non-profit medical-scientific association, established in 1983, with a current headquarters in Warsaw that unites nephrologists, physicians and other scholars, experts and professionals in the fields of kidney diseases, dialysis therapy and renal transplantation.

Lisa Robinson is a clinician-scientist. She is a University of Toronto professor in the Department of Paediatrics and the Dean of the Temerty Faculty of Medicine, former Head of the Division of Nephrology at The Hospital for Sick Children, a Senior Scientist at the SickKids Research Institute, President American Pediatric Society 2022-2023, and the first-ever Chief Diversity officer for the Faculty of Medicine at University of Toronto.

<span class="mw-page-title-main">Vanessa Grubbs</span> Nephrologist

Vanessa Grubbs is a nephrologist and a writer based in Oakland, California. She is an associate professor at the University of California, San Francisco. She works at Zuckerberg San Francisco General Hospital.

Jaquelyne Hughes FRACP is a Torres Strait Islander woman and senior research fellow at Menzies School of Health Research, Charles Darwin University. She also works as a nephrologist at the Royal Darwin Hospital.

<span class="mw-page-title-main">Andrew S. Levey</span> American nephrologist (born 1950)

Andrew S. Levey is an American nephrologist who transformed chronic kidney disease (CKD) clinical practice, research, and public health by developing equations to estimate glomerular filtration rate (GFR), and leading the global standardization of CKD definition and staging.

Gary V. Desir is a physician, researcher and medical practitioner who was appointed as the vice provost for faculty development and diversity at Yale University in March 2020. Desir is also the chair of the department of internal medicine at Yale School of Medicine, and was formerly the chair of the Yale Medicine Board. His areas of specialization include nephrology and molecular physiology, the latter specifically about potassium channels. His notable research work includes discovery of the kidney protein renalase.

Adeera Levin MD, FRCPC is a Professor of Medicine, and is head of the Division of Nephrology at University of British Columbia.

Rulan S. Parekh is an American-Canadian clinician-scientist and nephrologist. She is the vice president of research, education and innovation at Women's College Hospital and former senior scientist in Child Health Evaluative Sciences and Associate Chief of Clinical Research at SickKids.

Allison Audrey Eddy is a Canadian nephrologist. She was the inaugural Hudson Family Hospital Chair in Pediatric Medicine at British Columbia Children's Hospital and a clinician-scientist at the British Columbia Children's Hospital.

Morgan Erika Grams is an American nephrologist. She is the Co-Director of the Division of Precision Medicine, and the Susan and Morris Mark Professor in the Departments of Medicine and Population Health at NYU Langone Health.

Deidra C. Crews MD, ScM is an American nephrologist and epidemiologist. She is the Deputy Director of Johns Hopkins Center for Health Equity and a Professor of Medicine at Johns Hopkins School of Medicine. Crews research focuses on social drivers of disparities in kidney disease and hypertension.

References

  1. ↑ "Dr. Susan Quaggin, Medical Professor, Branksome Hall alumnus". ourkids.net. Retrieved November 26, 2019.
  2. 1 2 Lawrence, Susan (December 21, 2000). "Seats of Power". magazine.utoronto.ca. Retrieved November 26, 2019.
  3. 1 2 Anderson, Roger (June 3, 2013). "Quaggin Honored with International Nephrology Award". news.feinberg.northwestern.edu. Retrieved November 26, 2019.
  4. ↑ "Accolades". research.utoronto.ca. Spring 2003. Retrieved November 26, 2019.
  5. 1 2 Ayshford, Emily. "No Small Plans". magazine.nm.org. Retrieved November 26, 2019.
  6. ↑ "ProActive Disclosure of the Canada Research Chairs (2006)" (PDF). chairs-chaires.gc.ca. Retrieved November 26, 2019.
  7. ↑ "VEGF inhibition leads to renal thrombotic microangiopathy". med.nyu.edu. Retrieved November 26, 2019.
  8. 1 2 3 "Susan E. Quaggin, MD, FASN, Councilor". asn-online.org. Retrieved November 26, 2019.
  9. ↑ "2009 KFOC Medal for Research Excellence". kidney.ca. 2009. Retrieved November 26, 2019.
  10. ↑ "Editorial introductions". journals.lww.com. July 2011. Retrieved November 26, 2019.
  11. ↑ "Mount Sinai researchers' discovery has potential to impact treatments of kidney disease". research.lunenfeld.ca. October 15, 2012. Retrieved November 26, 2019.
  12. ↑ "Quaggin to Lead Cardiovascular Research Institute, Division of Nephrology". news.feinberg.northwestern.edu. June 19, 2012. Retrieved November 26, 2019.
  13. ↑ Paul, Marla (September 10, 2014). "Scientists Developing Eye Drops to Treat Blindness". news.feinberg.northwestern.edu. Retrieved November 26, 2019.
  14. ↑ Plumridge, Sarah (May 14, 2013). "Faculty Elected to Prestigious Societies at Joint Meeting". news.feinberg.northwestern.edu. Retrieved November 26, 2019.
  15. ↑ "Q BioMed Inc. Is Pleased To Announce A Letter-Of-Intent To Exclusively In-License And Ultimately Acquire The Assets Of Mannin Research Inc". biospace.com. September 21, 2015. Retrieved November 26, 2019.
  16. ↑ Horspool, Sally (October 12, 2015). "Susan Quaggin becomes ASN's newest councilor". theisn.org. Retrieved November 26, 2019.
  17. ↑ Rohman, Melissa (October 21, 2019). "Four Feinberg Faculty Elected to the National Academy of Medicine". news.feinberg.northwestern.edu. Retrieved November 26, 2019.
  18. ↑ Mladic, Nicole (2023-06-27). "New Leadership in the Department of Medicine". News Center. Retrieved 2024-02-14.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.